Industry Insights

  1. Biosimilars Producer, Alvotech, Finds Opportunities In Iceland
    5/11/2017

    In June 2016, the world’s attention was captivated by a modern-day David and Goliath sports story, as the national football team from the small island of Iceland reached the quarter finals of the UEFA Euro 2016 soccer tournament.

  2. End-to-end Technology Transfer Services In Oral Solids And Sterile
    3/29/2017

    In the pharmaceutical industry, “technology transfer” refers to the processes that are needed for successful progression of stages ranging from drug discovery, product development, clinical trials to full-scale commercialization or it is the transfer between development and commercialization at different sites within or outside an organization.

  3. Demand Led Supply Chain Approach Gets Medications To Clinical Sites Quickly
    5/25/2017

    An important measure of success of any clinical supply chain strategy is whether or not clinical sites have the necessary study medications at the ready when needed to avoid delays in new patient starts or continuance of therapy. Forecasting and demand simulations are useful for anticipating when and where stock is likely to be needed to formulate a kit production and distribution strategy.

  4. Important Considerations When Sourcing Reference Products For Biosimilar Studies
    5/25/2017

    Pharmaceutical companies face a number of challenges when sourcing comparator compounds for clinical trials, including addressing product lead times, availability, expiry limitations, safety or cost. Learn how clinical trial sponsors can determine the best strategy to meet these challenges.

  5. Six Myths About Serialization
    8/12/2016

     Biopharmaceutical companies that don’t comply will find it impossible to market their drugs in countries that have instituted serialization regulations.

  6. Sanofi Asks — Will Standardization Take End User & Supplier Relationships To The Next Level?
    2/10/2017

    To continue the evolution of single-use technology (SUT) in biopharma, one area that must be secured is SUT supply chain reliability. Without this, a larger scale adoption of SUT may continue to be delayed as biopharmaceutical manufacturers must have access to a reliable supply chain that allows us to successfully deliver product to our customers.

  7. 5 Questions To Answer Before Starting Your CMO Search
    3/17/2017

    Without careful consideration of what are the most important features you need from a CMO and preparing for what the CMO needs from you, the result can be a mismatch.

  8. Clinical Supply Chain Transformation Through Innovation
    4/28/2017

    An important measure of success of any clinical supply chain strategy is whether or not clinical sites have the necessary study medications at the ready when needed to avoid delays in new patient starts or continuance of therapy. The complex nature of some clinical trials can create challenges which can place considerable stress on the supply chain. The difficulty in ensuring the continuity of supply increases as variables are introduced into the mix. These variables can include blinded studies, those with multiple arms or dynamic designs such as adaptive studies, fluctuations in patient recruitment, insufficient or interrupted supply of the IMP or comparator drugs, and more.

  9. Pharmaceutical Primary Packaging Strategies
    5/25/2017

    Packaging and presentation is crucial to study success. Drug stability, regulatory strategy, and patient-centered design are just some of the factors to consider. Explore the best packaging strategies to achieve longer stability and adherence.

  10. Can The Cloud Prevent Collaboration Failure In Biopharma?
    5/20/2016

    Working in a cloud-based information management and collaboration workspace provides a level of business agility and security that is not available with server-based, on-premises infrastructure.